REPLACEMENT OF FROZEN THAWED EMBRYOS IN ARTIFICIAL AND NATURAL CYCLES - A PROSPECTIVE SEMI-RANDOMIZED STUDY

被引：74

作者：

SATHANANDAN, M ^{[1
]}

MACNAMEE, MC ^{[1
]}

RAINSBURY, P ^{[1
]}

WICK, K ^{[1
]}

BRINSDEN, P ^{[1
]}

EDWARDS, RG ^{[1
]}

机构：

[1] BOURN HALL CLIN,CAMBRIDGE CB3 7TR,ENGLAND

来源：

HUMAN REPRODUCTION | 1991年 / 6卷 / 05期

关键词：

ARTIFICIAL CYCLE; NATURAL CYCLE; FROZEN EMBRYO REPLACEMENT;

D O I：

10.1093/oxfordjournals.humrep.a137407

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

This prospective partly-randomized study assessed the relative efficacy of two strategies of patient management for the replacement of frozen-thawed embryos. A luteinizing hormone-releasing hormone (LHRH) agonist was used to induce a temporary hypogonadism in a group of patients who were then prepared for implantation by endometrial priming with hormone replacement therapy (HRT): oral oestradiol valerate and then oestradiol valerate and injections of progesterone. A second group of patients had their frozen-thawed embryos replaced during their natural cycles. Of the 84 patients treated with the LHRH regimen, 80 had embryos replaced and 16 (20%) clinical pregnancies were established. Of the 78 patients treated with natural cycles, 70 had embryos replaced and 14 (20%) achieved clinical pregnancies. There were no statistical differences between the two groups in terms of age, obstetric history, duration of infertility, number of oocytes retrieved and fertilized or the number of embryos frozen following ovarian stimulation in the embryo 'generating' cycle. In terms of pregnancy rates, both protocols were equally effective. However, the LHRH-HRT protocol was of great value in the management of oligomenorrhoeic patients and in establishing standard conditions for implantation in cyclic patients.

引用

页码：685 / 687

页数：3

共 16 条

[1]

Asch R.H., Balmaceda J.P., Ord T., Borrero C., Cefahi E., Gastaldi C., Rojas F., Oocyte donation and gamete intrafallopian transfer in premature ovarian failure, Fertil. Steril, 49, pp. 263-267, (1988)

[2]

Cameron I.T., Rogers P., Healy D.L., Leeton J.F., Thedevelopment of a flexible steroid replacement schedule for agonadal women undergoing in-vitro fertilization using donated oocytes, Sixth World Congress in I. V. F, (1989)

[3]

Cohcn J., Simons R.S., Fehilly C.B., Edwards R.G., Factors affecting survival and implantation of cryopreserved human embryos, Hi Vitro Fértil. Embryo Transfer, 3, pp. 46-52, (1986)

[4]

Cohen J., De Vane G.W., Elsner C.W., Fehilty C.B., Kort H.I., Massey J.B., Turner T.G., Cryopreservation of zygotes and early cleaved human embryos, Fértil. Sterii, 49, pp. 283-289, (1988)

[5]

Cohen J., De Vane G.W., Elsner C.W., Kort H.I., Massey J.B., Norbury S.E., Cryopreserved zygotes and embryos and endo cnnologic factors in the replacement cycle, Fértil. Sterii, 50, pp. 61-67, (1988)

[6]

Corolcu B., Veiga A., Moragas M., Calderon G., Barri P.N., The replacement of frozen thawed embryos: Natural or artificial cycles, Sixth World Congress, (1989)

[7]

Lamb Colliflower E.I.W.W., Williams J.W., Endometrial histology and conception rates after clomiphcne citrate, Obstet. Gynecol, 39, (1972)

[8]

Lassalle B., Testart J., Renard J.P., Human embryo features that influence the success of cryopreservation with the use of 1. 2 propanediol, Fend. Sterii, 44, pp. 645-651, (1985)

[9]

Lutzen P.J., Findlay J.K., Trounson A.O., Lccton J.F., Chan L.K., Effect of plasma gonadotrophins of cyclic steroid replacement in women with premature ovarian failure, J. Clin. Endocrinol Metab, 62, pp. 419-423, (1986)

[10]

Meldrum D.R., Wisot A., Hamilton P., Gutlay Yeo A.L., Marr B., Huynh D., Artificial agonadism and hormone replacement for oocyte donation, Fértil. Sterii, 52, pp. 509-511, (1989)

← 1 2 →